Neural retina-specific leucine zipper protein (NRL)

Neural retina-specific leucine zipper protein (NRL) is a Maf-family basic motif-leucine zipper (bZIP) transcription factor that is expressed specifically in retinal rod photoreceptors and, to a lesser extent, the pineal gland. NRL is both essential and sufficient for the specification and maintenance of rod photoreceptors, orchestrating the activation of rod-specific genes such as rhodopsin (RHO), phosphodiesterase 6B (PDE6B), and others involved in phototransduction and retinal development. Loss of NRL leads to a complete absence of rods and a retina composed only of cone photoreceptors, while ectopic expression can convert developing cones into rod-like cells, illustrating its pivotal role in cell fate determination. NRL operates within a network of interacting transcription factors (e.g., CRX, FIZ1, c-Jun) and is subject to regulation through posttranslational modifications, including phosphorylation and interaction with signaling proteins such as JNK1, as well as coactivators like Tip60 and RNA-binding proteins (e.g., DHX9). Mutations in NRL are a cause of autosomal dominant retinitis pigmentosa (adRP) and other hereditary retinopathies. No direct therapeutic drugs are currently listed as interacting with NRL, but the gene is considered a critical biomarker for inherited retinal disease diagnostics.

Other names

Neural retina leucine zipperNRLD14S46ERP27NRL-MAFMaf-family bZIP transcription factor NRLneural retina-specific leucine zipper proteinneural retinal-specific leucine zipper